Catalyst Wire Dossier Catalyst Wire Dossier

EMFLAZA

deflazacort · PTC Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for EMFLAZA, covering 2017-02-09 to 2024-06-05. Get the full timeline:

Most recent: FDA Approved: EMFLAZA — Supplemental Application (PTC Therapeutics, Inc.)

See pricing